antibody

Documents about antibody

• Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.#800204ClinicalTrials.gov
• The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients#185593IRIS
• Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies#442107ClinicalTrials.gov
• Biologically-Grounded Multi-Encoder Architectures as Developability Oracles for Antibody Design#5967arXiv CS
• COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios#95304PhilArchive
• Advanced CD276-Targeting Dual-Payload Antibody-Drug Conjugates for Cancer Therapy.#122713NCBI PubMed Central
• IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma#181776ClinicalTrials.gov
• Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose#230486ClinicalTrials.gov
• A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses#300946HAL (France)
• Miniaturization of multiplexed planar recombinant antibody arrays for serum protein profiling.#301368Lund University Publications
• Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivax#308268HAL (France)
• Mitigation of imprinted antibody responses in elderly COVID-19 highly vaccinated individuals#366443bioRxiv / medRxiv
• Computational design of structurally diverse antibody repertoires with drug-like properties#367252Europe PMC
• H3BERTa: A CDR-H3-specific language model for antibody repertoire analysis.#371455NCBI PubMed Central
• Cryo-EM structure of human LRRC15 reveals the basis of therapeutic antibody recognition#377088bioRxiv / medRxiv
• Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease.#404271NCBI PubMed Central
• Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)#435767ClinicalTrials.gov
• Antibody array generation and use.#452347Lund University Publications
• Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™#459953ClinicalTrials.gov
• Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer.#461120Lund University Publications
• The Rechallenge of ADCs in MBC Patients#811688ClinicalTrials.gov
• Avacostar - (PASS)#869691ClinicalTrials.gov
• Study of ESBA105 Eye Drops in Healthy Subjects#871292ClinicalTrials.gov
• Data Sheet 1_Case Report: Anti-GQ1b antibody–positive overlap syndrome: a pediatric case involving the brainstem, spinal cord, and peripheral nerves.docx#430070Figshare
• An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia#800344ClinicalTrials.gov
• Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients#836178ClinicalTrials.gov
• Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies#831363ClinicalTrials.gov
• A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases#846264ClinicalTrials.gov
• Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors#880654ClinicalTrials.gov
• Engineered hematopoietic stem cells give rise to therapeutic antibody secreting B cells#4782Europe PMC
• Accessing invasion-competent Plasmodium vivax merozoites reveals antibody-dependent NK cell activation#4802Europe PMC
• BCRInsight: an antibody language model to decode biological signals from BCR sequences.#13518NCBI PubMed Central
• Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities#67889ClinicalTrials.gov
• Optimization of pegylated iron oxide nanoplatforms for antibody coupling and bio-targeting#121824HAL (France)
• Antibody-antigen neutralization prediction by integrating structural information distillation and physicochemical constraints.#125361NCBI PubMed Central
• Fc-mediated antibody functions are associated with disease severity in COVID-19.#199145NCBI PubMed Central
• Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children#226324ClinicalTrials.gov
• CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery.#232602NCBI PubMed Central
• Prediction of antibody non-specificity using protein language models and biophysical parameters.#239685NCBI PubMed Central
• (COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies#245520ClinicalTrials.gov
• Characterizing local antibody responses in the muscle of inclusion body myositis patients.#247627NCBI PubMed Central
• Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer#272365ClinicalTrials.gov
• Structures of New World mammarenavirus glycoproteins as targets for antibody-mediated neutralization.#308953NCBI PubMed Central
• Efficient inference of non-polyreactive antibody variants dependent on local fine-tuning.#322964NCBI PubMed Central
• Microfluidic Immunomagnetic Capture of Circulating Tumor Cells via On-Bead Antibody Conjugation.#412293NCBI PubMed Central
• Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children#432921ClinicalTrials.gov
• Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives.#433837NCBI PubMed Central
• Experimental and computational analysis of glycan processing at increased monoclonal antibody productivities.#440715NCBI PubMed Central
• Anaphylaxis events following COVID-19 antiviral and neutralising monoclonal antibody treatment for non-hospitalised patients#452300LSHTM Data Compass
• Symptom evolution, persistence, and pharmacological management in paediatric NMDA receptor antibody encephalitis.#457603NCBI PubMed Central